2019
Conservative vs liberal fluid therapy in septic shock (CLASSIC) trial-Protocol and statistical analysis plan
MEYHOFF, T.S., P.B. HJORTRUP, M.H. MOLLER, J. WETTERSLEV, T. LANGE et. al.Základní údaje
Originální název
Conservative vs liberal fluid therapy in septic shock (CLASSIC) trial-Protocol and statistical analysis plan
Autoři
MEYHOFF, T.S. (garant), P.B. HJORTRUP, M.H. MOLLER, J. WETTERSLEV, T. LANGE, M.B.N KJR, A.B. JONSSON, C.J.S HJORTSO, M. CRONHJORT, J.H. LAAKE, S.M. JAKOB, M. NALOS, V. PETTIL, I. VAN DER HORST, M. OSTERMANN, P.. MOUNCEY, K. ROWAN, M. CECCONI, R. FERRER, M.L.N.G. MALBRAIN, C. AHLSTEDT, S. HOFFMANN, M.H. BESTLE, L. NEBRICH, L. RUSSELL, M. VANG, M.L. RASMUSSEN, C. SOLLING, B.S. RASMUSSEN, A.C. BROCHNER a A. PERNER
Vydání
Acta Anaesthesiologica Scandinavica, HOBOKEN, WILEY, 2019, 0001-5172
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30230 Other clinical medicine subjects
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 2.050
Kód RIV
RIV/00216224:14110/19:00124330
Organizační jednotka
Lékařská fakulta
UT WoS
000477274600001
Klíčová slova česky
INTENSIVE;CARESEPSIS;PROTOCOL; MISSING DATA; RESUSCITATION; MANAGEMENT; MORTALITY; VOLUMES; ADULTS
Klíčová slova anglicky
INTENSIVE;CARESEPSIS;PROTOCOL; MISSING DATA; RESUSCITATION; MANAGEMENT; MORTALITY; VOLUMES; ADULTS
Štítky
Změněno: 17. 5. 2022 13:17, Mgr. Tereza Miškechová
Anotace
V originále
Introduction Intravenous (IV) fluid is a key intervention in the management of septic shock. The benefits and harms of lower versus higher fluid volumes are unknown and thus clinical equipoise exists. We describe the protocol and detailed statistical analysis plan for the conservative versus liberal approach to fluid therapy of septic shock in the Intensive Care (CLASSIC) trial. The aim of the CLASSIC trial is to assess benefits and harms of IV fluid restriction versus standard care in adult intensive care unit (ICU) patients with septic shock. Methods CLASSIC trial is an investigator-initiated, international, randomised, stratified, and analyst-blinded trial. We will allocate 1554 adult patients with septic shock, who are planned to be or are admitted to an ICU, to IV fluid restriction versus standard care. The primary outcome is mortality at day 90. Secondary outcomes are serious adverse events (SAEs), serious adverse reactions (SARs), days alive at day 90 without life support, days alive and out of the hospital at day 90 and mortality, health-related quality of life (HRQoL), and cognitive function at 1 year. We will conduct the statistical analyses according to a pre-defined statistical analysis plan, including three interim analyses. For the primary analysis, we will use logistic regression adjusted for the stratification variables comparing the two interventions in the intention-to-treat (ITT) population. Discussion The CLASSIC trial results will provide important evidence to guide clinicians' choice regarding the IV fluid therapy in adults with septic shock.
Návaznosti
90090, velká výzkumná infrastruktura |
|